| GO:0097435 | supramolecular fiber organization | 4.55% (3/66) | 6.99 | 1e-06 | 0.000131 |
| GO:0007015 | actin filament organization | 4.55% (3/66) | 6.99 | 1e-06 | 0.000131 |
| GO:0016043 | cellular component organization | 9.09% (6/66) | 3.71 | 6e-06 | 0.000548 |
| GO:0071840 | cellular component organization or biogenesis | 9.09% (6/66) | 3.54 | 1.2e-05 | 0.000805 |
| GO:0003779 | actin binding | 4.55% (3/66) | 5.85 | 1.6e-05 | 0.000849 |
| GO:0010638 | positive regulation of organelle organization | 3.03% (2/66) | 6.72 | 0.000132 | 0.001718 |
| GO:0044089 | positive regulation of cellular component biogenesis | 3.03% (2/66) | 6.72 | 0.000132 | 0.001718 |
| GO:0034314 | Arp2/3 complex-mediated actin nucleation | 3.03% (2/66) | 6.72 | 0.000132 | 0.001718 |
| GO:0030838 | positive regulation of actin filament polymerization | 3.03% (2/66) | 6.72 | 0.000132 | 0.001718 |
| GO:0031334 | positive regulation of protein-containing complex assembly | 3.03% (2/66) | 6.72 | 0.000132 | 0.001718 |
| GO:0045010 | actin nucleation | 3.03% (2/66) | 6.72 | 0.000132 | 0.001718 |
| GO:1902905 | positive regulation of supramolecular fiber organization | 3.03% (2/66) | 6.72 | 0.000132 | 0.001718 |
| GO:0005885 | Arp2/3 protein complex | 3.03% (2/66) | 6.72 | 0.000132 | 0.001718 |
| GO:0051495 | positive regulation of cytoskeleton organization | 3.03% (2/66) | 6.72 | 0.000132 | 0.001718 |
| GO:0005856 | cytoskeleton | 3.03% (2/66) | 6.72 | 0.000132 | 0.001718 |
| GO:0032273 | positive regulation of protein polymerization | 3.03% (2/66) | 6.72 | 0.000132 | 0.001718 |
| GO:0043254 | regulation of protein-containing complex assembly | 3.03% (2/66) | 6.14 | 0.000327 | 0.002439 |
| GO:0110053 | regulation of actin filament organization | 3.03% (2/66) | 6.14 | 0.000327 | 0.002439 |
| GO:0051493 | regulation of cytoskeleton organization | 3.03% (2/66) | 6.14 | 0.000327 | 0.002439 |
| GO:0044087 | regulation of cellular component biogenesis | 3.03% (2/66) | 6.14 | 0.000327 | 0.002439 |
| GO:0090066 | regulation of anatomical structure size | 3.03% (2/66) | 6.14 | 0.000327 | 0.002439 |
| GO:0032970 | regulation of actin filament-based process | 3.03% (2/66) | 6.14 | 0.000327 | 0.002439 |
| GO:0032956 | regulation of actin cytoskeleton organization | 3.03% (2/66) | 6.14 | 0.000327 | 0.002439 |
| GO:0032535 | regulation of cellular component size | 3.03% (2/66) | 6.14 | 0.000327 | 0.002439 |
| GO:0032271 | regulation of protein polymerization | 3.03% (2/66) | 6.14 | 0.000327 | 0.002439 |
| GO:1902903 | regulation of supramolecular fiber organization | 3.03% (2/66) | 6.14 | 0.000327 | 0.002439 |
| GO:0008064 | regulation of actin polymerization or depolymerization | 3.03% (2/66) | 6.14 | 0.000327 | 0.002439 |
| GO:0030833 | regulation of actin filament polymerization | 3.03% (2/66) | 6.14 | 0.000327 | 0.002439 |
| GO:0030832 | regulation of actin filament length | 3.03% (2/66) | 6.14 | 0.000327 | 0.002439 |
| GO:0030234 | enzyme regulator activity | 4.55% (3/66) | 4.45 | 0.000339 | 0.002458 |
| GO:0015629 | actin cytoskeleton | 3.03% (2/66) | 7.14 | 6.6e-05 | 0.002461 |
| GO:0070569 | uridylyltransferase activity | 3.03% (2/66) | 7.14 | 6.6e-05 | 0.002461 |
| GO:0051130 | positive regulation of cellular component organization | 3.03% (2/66) | 6.4 | 0.000219 | 0.002595 |
| GO:0016071 | mRNA metabolic process | 4.55% (3/66) | 4.66 | 0.000216 | 0.002689 |
| GO:0005543 | phospholipid binding | 4.55% (3/66) | 4.99 | 0.000109 | 0.003162 |
| GO:0008289 | lipid binding | 4.55% (3/66) | 4.99 | 0.000109 | 0.003162 |
| GO:0005737 | cytoplasm | 4.55% (3/66) | 4.26 | 0.000499 | 0.003523 |
| GO:0008092 | cytoskeletal protein binding | 4.55% (3/66) | 4.22 | 0.000546 | 0.00375 |
| GO:0048518 | positive regulation of biological process | 3.03% (2/66) | 5.55 | 0.000778 | 0.004951 |
| GO:0030695 | GTPase regulator activity | 3.03% (2/66) | 5.55 | 0.000778 | 0.004951 |
| GO:0048522 | positive regulation of cellular process | 3.03% (2/66) | 5.55 | 0.000778 | 0.004951 |
| GO:0033043 | regulation of organelle organization | 3.03% (2/66) | 5.4 | 0.000969 | 0.006023 |
| GO:0051128 | regulation of cellular component organization | 3.03% (2/66) | 5.26 | 0.001181 | 0.00685 |
| GO:0008047 | enzyme activator activity | 3.03% (2/66) | 5.26 | 0.001181 | 0.00685 |
| GO:0098772 | molecular function regulator | 4.55% (3/66) | 3.85 | 0.001168 | 0.007091 |
| GO:0060589 | nucleoside-triphosphatase regulator activity | 3.03% (2/66) | 5.02 | 0.001665 | 0.009445 |
| GO:0035091 | phosphatidylinositol binding | 3.03% (2/66) | 4.92 | 0.001936 | 0.010752 |
| GO:0006397 | mRNA processing | 3.03% (2/66) | 4.26 | 0.004796 | 0.022761 |
| GO:0005094 | Rho GDP-dissociation inhibitor activity | 1.52% (1/66) | 7.72 | 0.004734 | 0.022881 |
| GO:0120009 | intermembrane lipid transfer | 1.52% (1/66) | 7.72 | 0.004734 | 0.022881 |
| GO:0120013 | lipid transfer activity | 1.52% (1/66) | 7.72 | 0.004734 | 0.022881 |
| GO:0006897 | endocytosis | 1.52% (1/66) | 7.72 | 0.004734 | 0.022881 |
| GO:0004427 | inorganic diphosphatase activity | 1.52% (1/66) | 7.72 | 0.004734 | 0.022881 |
| GO:0003885 | D-arabinono-1,4-lactone oxidase activity | 1.52% (1/66) | 7.72 | 0.004734 | 0.022881 |
| GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor | 1.52% (1/66) | 7.72 | 0.004734 | 0.022881 |
| GO:0032991 | protein-containing complex | 7.58% (5/66) | 2.14 | 0.005521 | 0.025733 |
| GO:0065008 | regulation of biological quality | 3.03% (2/66) | 3.92 | 0.007707 | 0.035288 |
| GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA | 1.52% (1/66) | 6.72 | 0.009446 | 0.039763 |
| GO:0110154 | RNA decapping | 1.52% (1/66) | 6.72 | 0.009446 | 0.039763 |
| GO:0044093 | positive regulation of molecular function | 1.52% (1/66) | 6.72 | 0.009446 | 0.039763 |
| GO:0043085 | positive regulation of catalytic activity | 1.52% (1/66) | 6.72 | 0.009446 | 0.039763 |
| GO:0110156 | methylguanosine-cap decapping | 1.52% (1/66) | 6.72 | 0.009446 | 0.039763 |